Industry Insights

• 
  A Brief Overview of Emerging Target: STEAP Xiaobin
  July 11, 2025
  As the "low-hanging fruit" in drug discovery becomes increasingly scarce, pharmaceutical companies are shifting their focus toward novel targets. At this year's AACR Annual Meeting, AstraZeneca unveiled preclinical data for AZD0516, a drug candidate targe
• 
  2025 Q1: Oncology Business Competition Among MNCs Xiaobin
  June 04, 2025
  How did MNCs fare in the oncology field during Q1 of this year?
• 
  Comparison of Improved New Drugs Paths between China and the United States and Analysis of R&D Status in China Kevin
  April 28, 2025
  This article describes successful practices from the United States 505(b)(2) pathway and analyzes R&D status of China's modified new drugs.

• 
  The Rising Demand for Macrolides & Aminoglycosides in Emerging Markets Saher Haider
  July 25, 2025
  Infectious diseases pose a significant public health burden across emerging markets, resulting in growing reliance on antibiotic therapies. This is where antibiotics like macrolides and aminoglycosides come in.

• 
  Alzheimer’s Disease: Charting the Course from Plaques to Promise Muhammad Farhan Khalid
  May 28, 2025
• 
  Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million ACN Newswire
  July 25, 2025
• 
  Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China ACN Newswire
  July 25, 2025
  Essex Bio-Technology Limited is pleased to announce that an indirect wholly-owned subsidiary, has received approval from AMPA for the registration and commercialisation of the multi-dose Diquafosol Sodium Eye Drops in the PRC.

• 
  Popular Products and Companies at PharmaSources.com (July 2025) PSI
  July 24, 2025
  Popular Products and Companies at PharmaSources.com
• 
  The Bitter Medicine is Good for Health: Research Progress on the Components and Pharmacological Activities of Coptis Chinensis Xiaomichong
  July 02, 2025
• 
  Popular Products and Companies at PharmaSources.com (January 2025) PSI
  January 15, 2025

• 
  Apeloa Pharmaceutical releases first ESG PharmaSources
  May 12, 2025
  Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.